Noticias de UTHR_US

Mercado

Noticias del mercado

Últimas noticias sobre UTHR_US — 297 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: UTHR_US ✕ 297 resultados
11/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares
10/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock By Investing.com
10/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock By Investing.com
10/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO sells 9,500 shares under 10b5-1 plan
09/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock By Investing.com
09/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock
09/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO exercises options and sells 9,500 shares in preset plan

CEO Martine Rothblatt's family trust exercised 9,500 options at $117.76 and sold 9,500 shares around $482–$504 under a 10b5-1 plan; 480,410 options remain.

09/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock By Investing.com
09/09/2026 UTHR_US — Investing.com
United Therapeutics CEO Martine Rothblatt sells $4.7m in stock
08/09/2026 UTHR_US — Minichart
United Therapeutics Launches $477.6M Accelerated Share Buyback
08/09/2026 UTHR_US — GuruFocus
United Therapeutics Corporation at Wells Fargo Healthcare Conference Transcript
08/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) moves to return $4B to shareholders with new buyback
08/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO sells 9,500 shares under preset trading plan
04/09/2026 UTHR_US — Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares under 10b5-1 plan
03/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) counsel sells 8,300 shares under preset plan
03/09/2026 UTHR_US — ChartMill
United Therapeutics (NASDAQ:UTHR) Fits the Growth-at-a-Reasonable-Price Model
03/09/2026 UTHR_US — Stock Titan
United Therapeutics (UTHR) CEO offloads 9,500 shares in planned trade
03/09/2026 UTHR_US — Kalkine Media
United Therapeutics EVP Paul A. Mahon Executes Stock Option Exercise and Sells Shares Under 10b5-1 Plan
03/09/2026 UTHR_US — UnionLeader.com
Anheuser-Busch plant in Merrimack sold to United Therapeutics for $47.5M

United Therapeutics Corp. continues its investment in New Hampshire’s life science industry with the purchase of the former Anheuser-Busch brewery on the Daniel Webster Highway in Merrimack for $47.5 million.

02/09/2026 UTHR_US — GuruFocus
United Therapeutics Corp (UTHR) Stock Down 4.1% but Still Overva

Página 9 de 15